LGC BIOSEARCH Webinars

 

Developing the 5-minute point-of-care PCR test: A technology revolutionising molecular diagnostics

Overview

The challenges we all faced at the peak of the COVID-19 pandemic are still very fresh in our memories. We know delivering point-of-care testing with speed, convenience, and reliability remains a pressing need in primary care. A resurgence in other respiratory pathogens, including influenza A and B, has left no respite for urgent care centres, general practice, and pharmacies as their testing services remain under pressure. The development and implementation of a PCR platform that could produce accurate results in just minutes, rather than hours would be transformative.

In this webinar, Andrew Anyakwo, Head of Reagent Development at LEX Diagnostics, will give a unique insight into how the company has been able to achieve just that – developing a low-cost, point-of-care PCR test that aims to diagnose SARS-CoV-2 and Flu A/B in just 5 minutes with high sensitivity and specificity.

Learning outcomes

• Understand the challenges that rapid development of assays/devices presents and how to overcome them.
• Gain insight into how to deal with inhibitors.
• Explore the benefits of partnering with a manufacturer to develop a solution with GMP scale.
• Discover how PCR can be improved to revolutionise point-of-care molecular diagnostics.

Speaker

Andrew Anyakwo
Head of Reagent Development
LEX Diagnostics